跳至主要内容
临床试验/NCT01818154
NCT01818154撤回不适用

Validation of a New Hand Held Light Emitting Diode (LED) Device for the Determination of Minimal Erythema Dose (MED) for Narrowband Ultraviolet B.

Henry Ford Health System2 个研究点 分布在 1 个国家开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Minimal Erythema Dose

研究概览

简要总结

The purpose of this study is to validate a new hand held light emitting diode (LED) device for the measurement of minimal erythema dose (MED) for narrow band Ultraviolet B (UVB) radiation by comparing to the traditional approach of measurement of the minimal erythema dose.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than 18 years.

排除标准

  • History of photosensitivity disorder
  • Photosensitizing medications
  • Personal history of melanoma or non-melanoma skin cancer.
  • Skin disease on the back

结局指标

主要结局

Minimal Erythema Dose

时间窗: 1 day

The Investigator will look at area irradiated and evaluate for erythema. The lowest dose at which erythema is noted will be recorded as the minimal erythema dose.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Iltefat Hamzavi

Senior Staff Physician

Henry Ford Health System

研究点 (2)

Loading locations...

相似试验